BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cerecor Inc. 

2400 Boston Street, Suite 324

Baltimore  Maryland  21224  U.S.A.
Phone: 410-522-8707 Fax: n/a


SEARCH JOBS





Segment
Start Up





 Company News
Cerecor Inc. To Present At 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/5/2014 8:05:28 AM
Cerecor Inc. Receives Fast Track Designation For CERC-301 For The Treatment Of Major Depressive Disorder 11/25/2013 12:35:12 PM
Cerecor Inc. Announces Initiation of Phase 2 Study for CERC-301, an Oral Rapid-acting Antidepressant Candidate 11/8/2013 10:00:47 AM
Cerecor Inc. to Present at 12th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/2/2013 7:33:47 AM
Cerecor Inc. Raises $6.8 Million in Series A-1 Financing 9/12/2013 7:46:55 AM
Cerecor Inc. to Present at Stifel Nicolaus Healthcare Conference 9/3/2013 7:18:45 AM
Cerecor Inc. to Present at Wedbush Securities Life Sciences Conference 8/13/2013 6:33:53 AM
Cerecor Inc. Granted U.S. Patent for Antitussive FP01 8/9/2013 9:31:30 AM
Cerecor Inc. Acquires Rights to NR2B Receptor Antagonist From Merck & Co., Inc. (MRK) 4/19/2013 9:03:55 AM
Cerecor Inc. Acquires Rights to Merck & Co., Inc. (MRK) COMT Inhibitors 3/20/2013 7:33:17 AM
12